10.1016/s0021-9258(19)88673-8 80 NakaD.ShimomuraT.YoshiyamaY.SatoM.SatoM.IshiiT.et al (1993)
We examine real-world outcomes and case examples that illustrate how GLP-1 therapies have improved patient health (for instance, reports of patients losing substantial weight and regaining metabolic control on these drugs ( [20] ) ( [21] ))
Together, these complementary mechanisms provide researchers with a broader understanding of tissue physiology than any individual peptide alone
Reported side effects are usually mild and short-lived
10.1254/jphs.fp0060070 88 PevecD.NovinscakT.BrcicL.SiposK.JukicI.StaresinicM.et al (2010)
Biomed Rep 4:519522 Honda Y, Kessoku T, Sumida Y, Kobayashi T, Kato T, Ogawa Y, Tomeno W, Imajo K, Fujita K, Yoneda M, Kataoka K, Taguri M, Yamanaka T, Seko Y, Tanaka S, Saito S, Ono M, Oeda S, Eguchi Y, Aoi W, Sato K, Itoh Y, Nakajima A (2017) Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study